Zusammenfassung
Angeborene Enzymstörung der Nebennierenrinden, meist 21-Hydroxylase-Mangel, seltener auch 11-Hydroxylase-Mangel.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allen DB, Hoffmann GI, Fitzpatrick P, Laessig R,Maby S, Slyper A (1997) Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17hydroxyprogesterone levels.J Pediatr 130: 128–133
Dixit N, Toresani T,Speiser PW (1998) Genotyping CYP21 as an adjunct to hormonal screening of newborns for CAH. 80th Annual Meeting of the Endocrine Society
Dörr HG, Sippel WG, Willig RP (1992) Pränatale Therapie und Diagnostik des adrenogenitalen Syndroms mit 21-Hydroxalysedefekt. Mschr Kinderheilk 140: 661–663
Gourmelen M, Gueux B, Pham HTM, Fiet J, Raux-Demay MC, Girard F (1987) Detection of heterocygote carriers for 21-hydroxylase deficiency by plasma 21-deoxycortisol measurement. Acta Endocrinol (Copenhagen) 116: 507–512
Harms E (1997) Richtlinien zur Organisation und Durchführung des Neugeborenenscreenings auf angeborene Stoffwechselstörungen und Endokrinopathien in Deutschland. Monatsschrift für Kinderheilkunde 7: 770–772
Heinrich UE, Milevicz A, Fies A, Romer T, Haack D (1985) The usefulness of plasma 21-deoxycortisol (21-DF) prior to and after ACTH for diagnosis, therapy and detection of heterocygotes in families with 21-hydroxylase deficiency. Acta Endocr Kbh, Suppl 267: 21
New MI (1994) 21-Hydroxylase deficiency congenital adrenal hyperplasia. J Steroid Biochem Molec Biol 48: 15–22
Miller WL (1994) Genetics, diagnosis and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 78: 241–246
Morel Y, Miller WL (1991) Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20: 1–68
Pang SY, Wallace MA, Hoffmann L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suewa S (1988) Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81: 866–874
Pang S, Shook MK (1997) Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Ped 9: 419–423
Speiser PW, Agdere L, Ueswhiba H, White PC, New MI (1991) Aldosterone synthesis in saltwasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. N Engl J Med 324: 145–149
Speiser PW, New MI (1994) Prenatal diagnosis and treatment of congenital adrenal hyperplasia. J Pediatr Endocrinol 7: 183–191
Schnabel D, l’Allemand D, Krude H, Keller E, Grüters A (2000) Ergebnisse des Neugeborenen-screenings zur Früherkennung des Adrenogenitalen Syndroms in Berlin (1992–1999) Monatsschrift für Kinderheilkunde 11: 1006–1011
Schulze E (1999) Neugeborenenscreening bei adrenogenitalem Syndrom (AGS). ScrJ/Sozialpädiatrie 11/12: 430
Speiser PW et al. (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90: 584–595
Therrell BL jr, Berenbaum SA, Manter-Kapanbke V, Simmank J, Kormann K, Prentice L, Gonzales J, Gunn S (1998) Results of screening 1,9 million Texas newborns for 21-hydroxylase-defrciency congenital adrenal hyperplasia. Pediatrics 101: 583–590
Thilen A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larson A (1998) Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase-deficiency) in Sweden. Pediatrics 101: E 11
Torresani T, Grüters A, Scherz R, Burckhardt JJ, Harras A, Zachmann M (1994) Improving theefficacyof newborn screening for congenital adrenal hyperplasia by adjusting the cut off level of 17-alpha-hydroxyprogesterone to gestational age. Screening 3: 77–84
Thomason MJ et al. (1998) A systematic review of evidence for the 3 appropriatness of neonatal screening programmes for inborn errors of metabolism. J Public Health Med 20: 331–343
Torresani T, Grüters A, Scherz R, Burckhardt JJ, Harras A, Zachmann M (1994) Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut off level of 17-alpha-hydroxyprogesterone to gestiational age. Screening 3: 77–84
Rights and permissions
Copyright information
© 2001 Springer-Verlag Wien
About this chapter
Cite this chapter
Zabransky, S., Schulze, E., Heinrich, U.E. (2001). Adrenogenitales Syndrom (AGS, 21-Hydroxylasemangel). In: Screening auf angeborene endokrine und metabole Störungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6252-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6252-1_19
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7260-5
Online ISBN: 978-3-7091-6252-1
eBook Packages: Springer Book Archive